YARDLEY, PA -- (MARKETWIRE) -- 03/31/08 -- On April 14-16, Almac
Clinical Technologies will be showcasing its fully integrated suite
of e-clinical technologies at the joint conference "Partnerships with
CROs" and "EDC & Beyond" (co-located at the Mandalay Bay Resort and
Casino in Las Vegas). "The built-in integration between our EDC and
IVR/IXRS (web and phone) solution allows sponsors to benefit from
workflow and cost efficiencies when working with Almac. Our
integrated technologies dramatically reduce redundant data entry,
time spent reconciling conflicting data, and help speed a study to
data lock," explains Jim Murphy, President of Almac Clinical
Almac's ability to provide a full range of integrated clinical
technology services leads to unique opportunities to partner with
CROs. Almac is looking at the CRO Partnerships meeting as an
opportunity to explore relationships with Clinical CROs, given the
value such arrangements would provide to clients.
"It is highly beneficial for sponsors to work with a clinical CRO and
a reputable technology vendor that work as part of an alliance. It
allows both the clinical CRO and the sponsor the flexibility to
best-of-breed technology without taking on the fixed costs associated
with developing and maintaining expensive technologies in-house. It's
an arrangement that works out great for the CRO and tech provider,
even more so for the client who receives the best solution for its
Fritz Haas, Vice President of New Products and Services, will be
presenting at EDC & Beyond on Tuesday afternoon about the role of EDC
technology as well as the value of integration between EDC and other
clinical technologies. Haas will also assess the current state of EDC
technology and discuss future possibilities for the technology.
"EDC is now at a tipping point in terms of adoption by sponsors for
clinical trials. In the past, EDC was looked upon mainly as a
solution for late stage trials involving large volumes of data or
complex designs. Today, however, sponsors are adopting early stage
methodologies such as translational medicine and 'learn and confirm'
which require data sharing between scientists and clinicians involved
in early stage development from discovery through proof-of-concept in
Phase II. Having all data in electronic form early for dissemination
and analysis across teams is vital to improving R&D productivity."
Come visit Almac at booth #412 in Las Vegas, where you'll have the
opportunity to demo a range of e-technology solutions and win various
Almac Clinical Technologies is a division of the Almac Group that
specializes in interactive technology and service solutions to
increase the quality and efficiency of the clinical trial process.
Our solutions include Interactive Voice and Web Response Systems
(IXRS(TM)) for patient randomization; tracking and clinical supply
management; iTrial EDC for electronic case report form data
collection; electronic patient reported outcome data collection; and
web drug reconciliation.
The Almac Group comprises five closely integrated divisions offering
a broad range of services from R&D, translational genomic services,
API manufacture, formulation development, clinical trial supply and
technology (IVRS/EDC), to commercial-scale manufacture. Almac
services to over 600 companies including all the world leaders in the
pharmaceutical and biotech sectors. The company employs over 2,000
individuals and is headquartered in Craigavon, Northern Ireland. US
operations are based in Pennsylvania, North Carolina and California.
T: (001) 267-685-4284